275 related articles for article (PubMed ID: 33933885)
41. Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.
Gori Savellini G; Anichini G; Manetti F; Trivisani CI; Cusi MG
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793572
[TBL] [Abstract][Full Text] [Related]
42. Viral and cellular translation during SARS-CoV-2 infection.
Eriani G; Martin F
FEBS Open Bio; 2022 Sep; 12(9):1584-1601. PubMed ID: 35429230
[TBL] [Abstract][Full Text] [Related]
43.
Rajendran M; Roy S; Ravichandran K; Mishra B; Gupta DK; Nagarajan S; Arul Selvaraj RC; Provaznik I
J Biomol Struct Dyn; 2022 Apr; 40(7):3155-3169. PubMed ID: 33200680
[TBL] [Abstract][Full Text] [Related]
44. Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).
de Lima Menezes G; da Silva RA
J Biomol Struct Dyn; 2021 Sep; 39(15):5657-5667. PubMed ID: 32657643
[TBL] [Abstract][Full Text] [Related]
45. Structural basis for translation inhibition by MERS-CoV Nsp1 reveals a conserved mechanism for betacoronaviruses.
Devarkar SC; Vetick M; Balaji S; Lomakin IB; Yang L; Jin D; Gilbert WV; Chen S; Xiong Y
Cell Rep; 2023 Oct; 42(10):113156. PubMed ID: 37733586
[TBL] [Abstract][Full Text] [Related]
46. Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2.
Wang Y; Kirkpatrick J; Lage SZ; Carlomagno T
Structure; 2023 Feb; 31(2):128-137.e5. PubMed ID: 36610391
[TBL] [Abstract][Full Text] [Related]
47. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
Kumar S; Kashyap P; Chowdhury S; Kumar S; Panwar A; Kumar A
Phytomedicine; 2021 May; 85():153317. PubMed ID: 32943302
[TBL] [Abstract][Full Text] [Related]
48. Structure of nonstructural protein 1 from SARS-CoV-2.
Clark LK; Green TJ; Petit CM
bioRxiv; 2020 Nov; ():. PubMed ID: 33173873
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
Schubert K; Karousis ED; Jomaa A; Scaiola A; Echeverria B; Gurzeler LA; Leibundgut M; Thiel V; Mühlemann O; Ban N
Nat Struct Mol Biol; 2020 Oct; 27(10):959-966. PubMed ID: 32908316
[TBL] [Abstract][Full Text] [Related]
50. Extended ensemble simulations of a SARS-CoV-2 nsp1-5'-UTR complex.
Sakuraba S; Xie Q; Kasahara K; Iwakiri J; Kono H
PLoS Comput Biol; 2022 Jan; 18(1):e1009804. PubMed ID: 35045069
[TBL] [Abstract][Full Text] [Related]
51. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
[TBL] [Abstract][Full Text] [Related]
52. Parsing the role of NSP1 in SARS-CoV-2 infection.
Fisher T; Gluck A; Narayanan K; Kuroda M; Nachshon A; Hsu JC; Halfmann PJ; Yahalom-Ronen Y; Tamir H; Finkel Y; Schwartz M; Weiss S; Tseng CK; Israely T; Paran N; Kawaoka Y; Makino S; Stern-Ginossar N
Cell Rep; 2022 Jun; 39(11):110954. PubMed ID: 35671758
[TBL] [Abstract][Full Text] [Related]
53. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an
Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S
J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689
[TBL] [Abstract][Full Text] [Related]
54. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.
Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN
Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443
[TBL] [Abstract][Full Text] [Related]
55. SARS-CoV-2 M
Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
[TBL] [Abstract][Full Text] [Related]
56. The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation.
Tidu A; Janvier A; Schaeffer L; Sosnowski P; Kuhn L; Hammann P; Westhof E; Eriani G; Martin F
RNA; 2020 Dec; 27(3):253-64. PubMed ID: 33268501
[TBL] [Abstract][Full Text] [Related]
57. Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM; Al-Hemaid F
J King Saud Univ Sci; 2022 Feb; 34(2):101810. PubMed ID: 35002180
[TBL] [Abstract][Full Text] [Related]
58. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
[TBL] [Abstract][Full Text] [Related]
59. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK
J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979
[TBL] [Abstract][Full Text] [Related]
60. SARS-CoV-2 Nsp1 suppresses host but not viral translation through a bipartite mechanism.
Shi M; Wang L; Fontana P; Vora S; Zhang Y; Fu TM; Lieberman J; Wu H
bioRxiv; 2020 Sep; ():. PubMed ID: 32995777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
